MDT
NYSE · Health Care
Medtronic Plc
$102.90
-0.05 (-0.05%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 33.33B | 32.71B | 36.48B | 38.01B | 39.84B |
| Net Income | 4.63B | 4.09B | 5.48B | 5.01B | 5.11B |
| EPS | — | — | — | — | — |
| Profit Margin | 13.9% | 13.2% | 15.0% | 13.2% | 12.8% |
| Rev Growth | +1.9% | +1.9% | -4.7% | +7.6% | +8.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 24.57B | 24.57B | 40.33B | 46.06B | 47.08B |
| Total Equity | 41.39B | 41.39B | 62.40B | 64.44B | 73.11B |
| D/E Ratio | 0.59 | 0.59 | 0.65 | 0.71 | 0.64 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 8.00B | 7.46B | 9.47B | 10.33B | 9.57B |
| Free Cash Flow | — | — | 6.14B | 5.93B | 5.01B |